Molecular Cancer Research

Aims & Scope

Molecular Cancer Research publishes articles describing novel basic cancer research discoveries of broad interest to the field.

Studies must be of demonstrated significance, and the journal prioritizes analyses performed at the molecular and cellular level that reveal novel mechanistic insight into pathways and processes linked to cancer risk, development, and/or progression.

Areas of emphasis include all cancer-associated pathways (including cell-cycle regulation; cell death; chromatin regulation; DNA damage and repair; gene and RNA regulation; genomics; oncogenes and tumor suppressors; signal transduction; and tumor microenvironment), in addition to studies describing new molecular mechanisms and interactions that support cancer phenotypes.

For full consideration, primary research submissions must provide significant novel insight into existing pathway functions or address new hypotheses associated with cancer-relevant biologic questions.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	4.7
2024	4.10

SJR (SCImago Journal Rank)

Year	Value
2024	1.748

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	156

Journal Rank

Year	Value
2024	1823

Journal Citation Indicator

Year	Value
2024	1946

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Histone Deacetylase Inhibitors: Overview and Perspectives

  Citation: 946

  Authors: Milos, Cathy, Paul A.

• Inflammation, a Key Event in Cancer Development

  Citation: 812

  Authors: Haitian, Weiming, Chuanshu

• Biochemical and Structural Analysis of Common Cancer-Associated KRAS Mutations

  Citation: 655

  Authors: John C., Anuj, Martin A., Deepak, Sudershan, Kenneth D.

• Antibody–Drug Conjugates: A Comprehensive Review

  Citation: 648

  Authors: Puregmaa, Cai Jia, Farhan Ullah, Awais Ullah, Juan

• Aldehyde Dehydrogenase 1 Is a Tumor Stem Cell-Associated Marker in Lung Cancer

  Citation: 623

  Authors: Feng, Qi, Abha, Nevins W., Janaki, Lingxiao, Huijun, Zhenqiu, Yun, Sanford A., Ruth L.

• Circulating Tumor Cells from Patients with Advanced Prostate and Breast Cancer Display Both Epithelial and Mesenchymal Markers

  Citation: 543

  Authors: Andrew J., Matthew S., Sebastian, Gabor, Rhonda L., James D., Christina I., Paul K., Daniel J., Mariano A.

• Roles of Aurora Kinases in Mitosis and Tumorigenesis

  Citation: 475

  Authors: Jingyan, Minglei, Qing, Chuanmao

• Cancer-Associated Fibroblasts Drive the Progression of Metastasis through both Paracrine and Mechanical Pressure on Cancer Tissue

  Citation: 431

  Authors: George S., Theofilos, Susan E., Richard, Robert H., Eleftherios P.

• IL-6 Promotes Head and Neck Tumor Metastasis by Inducing Epithelial–Mesenchymal Transition via the JAK-STAT3-SNAIL Signaling Pathway

  Citation: 412

  Authors: Arti, Bhavna, Jharna, Theodoros N., Pawan

• Transcriptome Profile of Human Colorectal Adenomas

  Citation: 398

  Authors: Jacob, Laurens G., Mariagrazia, Elisa, Caroline, Hubert, Endre, Michal A., Janusz M., Mirco, Judith, Teresa V., Vito, Alfredo, Roberto, Marcello, Josef, Hans, Giancarlo

---